These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 549000)

  • 1. Oxalic acid concentration in serum measured by isotopic clearance technique. Experience in hyper- and normo-oxaluric subjects.
    Prenen JA; Mees EJ; Boer P; Endeman HJ; Ephraim KH
    Proc Eur Dial Transplant Assoc; 1979; 16():566-70. PubMed ID: 549000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of oxalic acid clearance and plasma concentration by radioisotope infusion. Results in a family with hyperoxaluria.
    Prenen JA; Boer P; Dorhout Mees EJ; Endeman HJ; Yoe OH
    Acta Med Scand; 1981; 209(1-2):87-91. PubMed ID: 7211493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Nephrol Dial Transplant; 1989; 4(9):792-9. PubMed ID: 2516611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies of oxalate in man.
    Hautmann R; Osswald H
    Invest Urol; 1979 Mar; 16(5):395-8. PubMed ID: 429137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalate retention in chronic renal failure: tubular vs glomerular diseases.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Clin Nephrol; 1989 Aug; 32(2):87-95. PubMed ID: 2788548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential studies of oxalate dynamics in primary hyperoxaluria.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1983 Dec; 65(6):627-33. PubMed ID: 6627848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional oxalate clearance in subjects with normal and impaired renal function.
    Boer P; Prenen JA; Koomans HA; Dorhout Mees EJ
    Nephron; 1985; 41(1):78-81. PubMed ID: 4033845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Evidence for renal hyperoxaluria.
    Kasidas GP; Nemat S; Rose GA
    Clin Chim Acta; 1990 Oct; 191(1-2):67-77. PubMed ID: 2073734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals.
    Huang HS; Ma MC; Chen J; Chen CF
    Neurourol Urodyn; 2003; 22(2):176-82. PubMed ID: 12579636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta 2 microglobulin. Index of glomerular filtration in children].
    Leroy D; Mauriat F; Dechaux M; Chopin N; Broyer M; Sachs C
    Arch Fr Pediatr; 1984 Jan; 41(1):43-7. PubMed ID: 6372730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length/serum creatinine ratio does not predict measured creatinine clearance in critically ill children.
    Fong J; Johnston S; Valentino T; Notterman D
    Clin Pharmacol Ther; 1995 Aug; 58(2):192-7. PubMed ID: 7648769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma oxalate concentration in calcium oxalate stone formers].
    Hoshina A
    Hinyokika Kiyo; 1984 Oct; 30(10):1405-15. PubMed ID: 6524552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal clearance of [14C]oxalate: comparison of constant-infusion with single-injection techniques.
    Prenen JA; Boer P; Mees EJ; Endeman HJ; Spoor SM; Oei HY
    Clin Sci (Lond); 1982 Jul; 63(1):47-51. PubMed ID: 7083764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma oxalate concentration and oxalate distribution volume in patients with normal and decreased renal function.
    Prenen JA; Dorhout Mees EJ; Boer P
    Eur J Clin Invest; 1985 Feb; 15(1):45-9. PubMed ID: 3921382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary oxalic acid excretion in chronic kidney failure and after kidney transplantation].
    Mydlík M; Derzsiová K; Pribylincová V; Reznícek J
    Vnitr Lek; 1996 Dec; 42(12):813-7. PubMed ID: 9072879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is serum cystatin C the marker of choice to predict glomerular filtration rate in paediatric patients?
    Willems HL; Hilbrands LB; van de Calseyde JF; Monnens LA; Swinkels DW
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):60-4. PubMed ID: 12542911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.